SFCM
TNGX icon

Seven Fleet Capital Management’s Tango Therapeutics TNGX Stock Holding History

Seven Fleet Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
502,012
+286,840
+133% +$3.99M 3.3% 2
2025
Q4 		$1.91M Buy
+215,172
New +$1.85M 1.29% 12

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Seven Fleet Capital Management's TNGX Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Tango Therapeutics (TNGX) stake by 133% in Q1 2026, buying an estimated $3.99M and bringing the position to 502,012 shares worth $10.5M. The position accounts for 3.3% of the portfolio, ranked #2.

Seven Fleet Capital Management first reported a position in TNGX in Q4 2025 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Seven Fleet Capital Management held 502,012 shares of Tango Therapeutics worth $10.5M as of Q1 2026.
  • Seven Fleet Capital Management bought 286,840 Tango Therapeutics shares in Q1 2026, an estimated $3.99M.
  • Tango Therapeutics made up 3.3% of Seven Fleet Capital Management's portfolio in Q1 2026, its #2 holding.
  • Seven Fleet Capital Management first reported a position in Tango Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.